Reinforced Ventures
VC Fund
Pittsburgh, United States
Reinforced Ventures is a VC fund in Pittsburgh focused on Software and Robotics. Reinforced Ventures is focused on helping founders with both capital and expertise at seed or pre-seed stages leveraging our network of over 1,600 engineers, entrepreneurs, and scientists.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Reinforced Ventures invests in
Stages Reinforced Ventures invests in
Countries Reinforced Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $789k–$8.8M
- Pre-Seed
- $125k–$5M
- Series A
- $12M–$22M
Investment Focus
Industry
- Software 10 (18%)
- Robotics 9 (16%)
- Artificial Intelligence 9 (16%)
- Biotechnology 8 (14%)
- Machine Learning 8 (14%)
Stage
- Seed 29 (52%)
- Pre-Seed 17 (30%)
- Series A 3 (5%)
- Series B 1 (2%)
Country
- United States 31 (55%)
- Canada 3 (5%)
- Israel 3 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Euan Guttridge
Founder
|
Founder | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Integrated Biosciences
|
Integrated Biosciences is the first company in history to be able to virtually stress cells. | $17.2M / Seed / Oct 03, 2024 | |
| Additive Space Technologies uses additive manufacturing systems, a machine-learning collaborative system for building vehicles and infrastructure on Earth, the Moon, or Mars. | $5M / Pre-Seed / Jul 17, 2024 | ||
| Enigma Aerospace focuses on developing autonomous aerial logistics technologies targeted at defense and B2B markets. They aim to redefine logistics through advanced drone technologies, highlighting a significant opportunity in the global logistics and air cargo markets. The company's focus includes creating solutions that enhance efficiency inpackage delivery and related logistics services | $1.6M / Pre-Seed / Jan 18, 2024 | ||
| Biophysical Therapeutics uses computational biology to design new drugs. It has a pipeline of experimentally-validated new drugs. Its primary targets are cancer, diseases of aging (e.g., Alzheimer's disease), and aging itself. Also pursuing cosmetics. Has a record of discovering new fundamental biology. Owns [by granted patents] inventedpreclinical, and repurposed clinical, stage drugs. Company has and is prosecuting longevity drug candidates (drugs to slow, halt or reverse aging). A longevity company. Professor George Church (of Harvard Medical School) is an Advisor. Scientist founder, Dr. Michael Forrest, is a Cambridge University biochemistry graduate with a Ph.D. in computer science. | $190K / Pre-Seed / Jun 05, 2023 | ||
| Ottometric provides an intelligent verification framework that gives deeper understanding of events and anomalies, helping the industry deliver safer vehicles. The race to get reliable ADAS features to vehicles is speeding up, from driver assistance to full self driving. The industry is investing greatly to innovate. Today, the auto industry isdelivering Level 1 to Level 3 Autonomous capabilities that industry stakeholders have called out as sub-par. | $4.9M / Seed / Jan 18, 2023 | ||
| SAFA was built to reduce the cost and effort associated with evolving and reusing safety cases while maintaining safety. | $390K / Pre-Seed / Dec 11, 2022 | ||
| Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting smallmolecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA. | $3.6M / Seed / Oct 17, 2022 | ||
|
Integrated Biosciences
|
Integrated Biosciences is the first company in history to be able to virtually stress cells. | Pre-Seed / Sep 01, 2022 | |
| Lemurian Labs has created a universal platform that works across any hardware and spans compiler technology and runtime orchestration. This streamlined, hardware-agnostic approach simplifies AI development, enabling organizations to write code once and deploy it seamlessly across edge, cloud and on-premise environments. By cutting through thecomplexity of fragmented software ecosystems, Lemurian Labs empowers businesses to build and scale AI efficiently, affordably and responsibly—unlocking the full potential of AI innovation without proprietary constraints. | Seed / Aug 22, 2022 | ||
| EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020. | Seed / Jul 12, 2022 | ||
| See all 56 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Reinforced Ventures invest in?
Reinforced Ventures invests primarily in Software, Robotics and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 56 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Reinforced Ventures invest in?
Reinforced Ventures typically joins rounds of $789k–$8.8M at Seed, $125k–$5M at Pre-Seed and $12M–$22M at Series A. These are whole funding-round sizes, not Reinforced Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Reinforced Ventures took part in.
How do I contact Reinforced Ventures?
Public channels for Reinforced Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Reinforced Ventures?
The team at Reinforced Ventures includes Euan Guttridge (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
